NanoGlass™: Unlocking Oral Exposure for bRo5 Molecules

Thu, Oct 29 | 03:45 PM - 03:52 PM
Gardner

Session details:

  • How NanoGlass™ formulations generate and stabilise amorphous API nanoparticles upon dissolution.
  • How this approach addresses solubility, dissolution rate and apparent permeability challenges in bRo5 molecules.
  • In vivo results from a series of bRo5 molecules, showing the potential to improve oral exposure.

Drug Delivery Technology Presentation Tracks:
3A: Oral, Nasal, Pulmonary & Other Non-Injectable Technologies
Track:
Drug Delivery Technology Presentation Tracks